Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 9/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20873213 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL2789146 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL10703302 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL9354133 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL7044918 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL7044585 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL1354834 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL8205797 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL21679740 | 0.97 | LMNA (0.46) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| SCHEMBL21679715 | 0.97 | LMNA (0.46) | LMNATSHRALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117658530-B | Processing technology of environment-friendly anti-cracking color recycled asphalt concrete | 淮南市中岩新型建材有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-118290692-A | Polyurethane nonpolar branched polymer, preparation method thereof and polyurethane nonpolar waterproof coating | 北京东方雨虹防水技术股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-117658530-A | Processing technology of environment-friendly anti-cracking color recycled asphalt concrete | 淮南市中岩新型建材有限公司 | 2024-03-08 | — | — | CN | claimed |
| EP-3501488-B1 | AQUEOUS SILICONE POLYMER COMPOSITIONS | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2021-04-14 | — | — | EP | claimed |
| US-10947383-B2 | Aqueous silicone polymer compositions | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2021-03-16 | — | — | US | claimed |
| US-20190194457-A1 | AQUEOUS SILICONE POLYMER COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2019-06-27 | — | — | US | claimed |
| EP-3501488-A1 | AQUEOUS SILICONE POLYMER COMPOSITIONS | Momentive Performance Materials GmbH (DE) | 2019-06-26 | — | — | EP | claimed |
| US-20260001838-A1 | NANOMATERIALS | GUIDE THERAPEUTICS LLC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12435035-B2 | Nanomaterials | GUIDE THERAPEUTICS, LLC (US) | 2025-10-07 | — | — | US | disclosed |
| EP-4617244-A1 | RADIATION CURABLE COMPOSITION FOR FORMING OPTICAL FIBER PRIMARY COAT LAYER, AND URETHANE (METH)ACRYLATE | Japan Fine Coatings Co., Ltd. (JP) | 2025-09-17 | — | — | EP | disclosed |
| CN-119684140-A | Nanomaterial for the preparation of a nanoparticle | 盖德治疗有限责任公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119638948-A | Solvent polyurethane resin and application thereof to base cloth | 江苏华峰超纤材料有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-115175894-B | Nanomaterial for the preparation of a nanoparticle | 盖德治疗有限责任公司 | 2024-09-06 | — | — | CN | disclosed |
| US-20030174377-A1 | Electrochromic polymers and polymer electrochromic devices | UNIVERSITY OF FLORIDA | 2003-09-18 | — | — | US | disclosed |
| WO-2003046106-A1 | ELECTROCHROMIC POLYMERS AND POLYMER ELECTROCHROMIC DEVICES | UNIVERSITY OF FLORIDA (US) | 2003-06-05 | — | — | WO | disclosed |
| US-20030081432-A1 | Electrolytic polymerization of aromatic hydrocarbons such as fluorene in the presence of an ester; oxidizing resulting polymer to produce a cyclopentanone-containing polymer such as poly(9-fluorenone); light emitting diodes | IM&T RESEARCH, INC. | 2003-05-01 | — | — | US | disclosed |
| US-20030066757-A1 | Method for preparing polymers containing cyclopentanone structures | IM&T RESEARCH, INC. | 2003-04-10 | — | — | US | disclosed |
| EP-1219677-A1 | FLAME RETARDANTS FOR RESINS AND FLAME-RETARDED RESIN COMPOSITIONS CONTAINING THE SAME | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-6127464-A | FLAME RETARDER FOR THERMOPLASTIC OR THERMOSETTING RESIN | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2000-10-03 | — | — | US | disclosed |
| EP-0924249-A1 | Phosphoric ester, process for preparing the same and use thereof | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001838-A1 | NANOMATERIALS | SLC10A1, NPC1L1, FABP1 | LMNA 355/4885TSHR 2311/4885ALDH1A1 619/4885 |
| US-12435035-B2 | Nanomaterials | NPC1, NPC1L1, FABP1 | LMNA 68/4885TSHR 2397/4885ALDH1A1 984/4885 |
| US-10947383-B2 | Aqueous silicone polymer compositions | CUTA, IL6, SHC1 | LMNA 1981/4885TSHR 4552/4885ALDH1A1 4298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.